As shown in Table 4 , the END rate of the argatroban plus DAPT group was lower than that of the DAPT group but did not reach statistical significance (0% vs 5.9%, P = .298).
← all excerpts
Effect of Argatroban Combined With Dual Antiplatelet Therapy on Early Neurological Deterioration in Acute Minor Posterior Circulation Ischemic Stroke.
1
0.2980
0.2980